Andrew J Perlman

Title: The Innovations of Andrew J Perlman

Introduction

Andrew J Perlman is a notable inventor based in Stanford, CA, with a remarkable portfolio of 14 patents. His work primarily focuses on advancements in the treatment of pruritus and related conditions. Perlman's contributions to the field of pharmaceuticals have made significant impacts on patient care and treatment options.

Latest Patents

Among his latest patents, Perlman has developed methods for treating pruritus using NK-1 receptor antagonists, specifically serlopitant. This invention includes pharmaceutical compositions that utilize NK-1 receptor antagonists to alleviate pruritus. Furthermore, his patents encompass the treatment of pruritus-associated conditions with serlopitant, potentially in combination with additional antipruritic agents. Notably, Perlman has also explored the use of serlopitant as a sleep aid, either alone or in conjunction with other sleep-aiding agents.

Career Highlights

Throughout his career, Andrew J Perlman has worked with prominent companies such as Menlo Therapeutics Inc. and Tigercat Pharma, Inc. His innovative approaches and dedication to research have positioned him as a leader in his field.

Collaborations

Perlman has collaborated with esteemed colleagues, including Xiaoming Zhang and Edward F Schnipper, contributing to the advancement of pharmaceutical research and development.

Conclusion

Andrew J Perlman's contributions to the field of pharmaceuticals, particularly in the treatment of pruritus, highlight his innovative spirit and dedication to improving patient outcomes. His extensive patent portfolio reflects his commitment to advancing medical science and enhancing therapeutic options.